arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Eton Pharmaceuticals, Inc.

ETON

$44.57 ▼ -1.56 (-3.38%) at close

9 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Eton Pharmaceuticals, Inc. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.2B

Dividend Yield —

Revenue Growth 104.9% ↗

Op. Margin -1.1% ↗

ROIC -1.8% ↗

FCF / Share $0.38 ↗

Trailing P/E —

Price / Book 46.1x

FCF Yield 0.9%

Debt / Equity 0.83

info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$79.95M

↑ +104.9% —

Net Income Profit after all expenses

$-4.60M

↓ -20.4% —

Operating Margin Operating profit as % of sales

-1.1%

↑ +84.1% 26th

FCF / Share Free cash flow per share

$0.38

↑ +940.0% —

Long-Term Debt Long-term obligations

$21.77M

↓ -27.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	104.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1212%)	23.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+191%)	48.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+511%)	-2.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-133%)	55879.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+698394%)	-95.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1299%)	—	—	—
EPS Growth YoY (%)	-13.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-275.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	88.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-350.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-20.4% Weak ↑ Weak Improving Year-over-year change in net income	-308.4% Weak ↓ Weak Declining Year-over-year change in net income	89.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-361.4% Weak ↓ Weak Declining Year-over-year change in net income	93.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-52.7% Weak Weak Year-over-year change in net income	-43.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	940.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-86.3% Weak Weak Year-over-year change in free cash flow	39.7% Excellent Excellent Year-over-year change in free cash flow	N/M	—	—	—	—	—
Revenue CAGR 3Y (%)	55.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	21.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	832.7% Excellent Excellent Compound annual revenue growth over 3 years	180.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	359.6% Excellent Excellent Compound annual revenue growth over 5 years	109.8% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	-1.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-107%)	-6.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-144%)	-3.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-125%)	-38.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-359%)	-6.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-146%)	—	—	—	—
Effective Tax Rate (%) (%)	-0.9% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-35.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
Profit Margin (%) (%)	-5.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-148%)	-9.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-182%)	-3.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-125%)	-42.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-454%)	-9.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-175%)	—	—	—	—
FCF Margin (%) (%)	12.7% Fair ↓ Fair Declining Free cash flow as a percentage of revenue Optimal: > 10%	2.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	21.5% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	22.5% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-21.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	-2.21x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.25x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-7.28x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.42x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-1.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-44.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-96.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-97.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-31.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-0.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-103.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-109.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-36.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-17.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-217%)	-15.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	-6.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	-69.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-560%)	-11.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-178.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1290%)	-173.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1258%)	-48.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-423%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Debt to Equity (x)	0.83x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+39%)	1.22x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+103%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.41x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-31%)	0.30x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-50%)	0.42x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-30%)	0.43x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-28%)	—	—
Interest Coverage (x)	-0.18x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.30x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.65x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.43x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-30.67x Weak Weak Operating income divided by interest expense Optimal: > 5x	-189.81x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-4.17M	$14.88M	$-21.39M	$-10.92M	$-9.14M	$-14.76M	$-7.53M	$-26.73M	$-13.16M
Debt / EBITDA (x)	-27.11x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-11.70x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.66x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.93x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.24x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.24x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	$2.97	$1.51	$1.23	$0.85	$0.87	—	—	—	—
Basic EPS, GAAP (USD)	$-0.17	$-0.15	$-0.04	$-0.36	$-0.08	—	—	—	—
Free Cash Flow per Share (USD)	$0.38	$0.04	$0.27	$0.19	$-0.19	—	—	—	—
Book Value per Share (USD)	$0.97	$0.91	$0.60	$0.52	$0.72	$0.64	$0.59	$1.49	$-1.15
Tangible Book Value per Share (USD)	$-0.17	$-0.39	$0.42	$0.33	$0.57	$0.62	$0.55	$1.49	$-1.15
Basic Weighted Avg Shares (shares)	26.91M	25.90M	25.65M	25.15M	25.21M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$22.09M	$21.07M	$10.60M	$13.54M	$19.05M	$20.91M	$13.05M	$25.48M	$12.50M
LT Debt (USD)	$21.77M	$29.81M	$0.00	$5.38M	$5.26M	$6.53M	$4.54M	—	—
Total Equity (USD)	$26.15M	$24.43M	$15.48M	$13.08M	$17.63M	$15.66M	$10.55M	$26.30M	$-6.87M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$79.95M	$39.01M	$31.64M	$21.25M	$21.83M	$39.00K	$959.00K	—	—
Depreciation Expense (USD)	$41.00K	$50.00K	$44.00K	$66.00K	$155.00K	$347.00K	—	$51.00K	—
Net Income, GAAP (USD)	$-4.60M	$-3.82M	$-936.00K	$-9.02M	$-1.96M	$-27.97M	$-18.32M	$-12.74M	—
Operating Cash Flow (USD)	$10.52M	$969.00K	$6.82M	$4.82M	$-4.72M	$-22.35M	$-18.03M	$-8.14M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 35 quarters

Eton Pharmaceuticals, Inc.

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ETON with peers